Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial.

Bosch J, Thabut D, Albillos A, Carbonell N, Spicak J, Massard J, D'Amico G, Lebrec D, de Franchis R, Fabricius S, Cai Y, Bendtsen F; International Study Group on rFVIIa in UGI Hemorrhage..

Hepatology. 2008 May;47(5):1604-14. doi: 10.1002/hep.22216.

PMID:
18393319
2.

Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia.

Stanworth SJ, Birchall J, Doree CJ, Hyde C.

Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005011. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD005011.

PMID:
17443565
3.

Coagulopathic patients with traumatic intracranial bleeding: defining the role of recombinant factor VIIa.

Bartal C, Freedman J, Bowman K, Cusimano M.

J Trauma. 2007 Oct;63(4):725-32. Review.

PMID:
18089997
4.

Efficacy and safety of recombinant activated factor VII to control bleeding in nonhemophiliac patients: a review of 17 randomized controlled trials.

Hardy JF, Bélisle S, Van der Linden P.

Ann Thorac Surg. 2008 Sep;86(3):1038-48. doi: 10.1016/j.athoracsur.2008.05.013. Review.

PMID:
18721620
5.

Successful treatment of severe gastrointestinal bleeding secondary to Crohn disease with recombinant factor VIIa.

Girona E, Borrás-Blasco J, Conesa-García V, Navarro-Ruiz A, Solís J, García-Sepulcre MF, Oliver-García I.

South Med J. 2007 Jun;100(6):601-4. Review.

PMID:
17591314
6.

Endoscopic injection of cyanoacrylate glue versus other endoscopic procedures for acute bleeding gastric varices in people with portal hypertension.

Ríos Castellanos E, Seron P, Gisbert JP, Bonfill Cosp X.

Cochrane Database Syst Rev. 2015 May 12;(5):CD010180. doi: 10.1002/14651858.CD010180.pub2. Review.

PMID:
25966446
7.

The use of recombinant factor VIIa in liver diseases.

Franchini M, Montagnana M, Targher G, Zaffanello M, Lippi G.

Blood Coagul Fibrinolysis. 2008 Jul;19(5):341-8. doi: 10.1097/MBC.0b013e32830496a7. Review.

PMID:
18600080
8.

Evidence-based Emergency Medicine/Critically Appraised Topic. The efficacy of recombinant activated factor VII in severe trauma.

Nishijima DK, Zehtabchi S.

Ann Emerg Med. 2009 Nov;54(5):737-744.e1. doi: 10.1016/j.annemergmed.2009.01.027. Epub 2009 Mar 14. Review.

PMID:
19285753
9.

A meta-analysis of the efficacy and safety of recombinant activated factor VII for patients with acute intracerebral hemorrhage without hemophilia.

Yuan ZH, Jiang JK, Huang WD, Pan J, Zhu JY, Wang JZ.

J Clin Neurosci. 2010 Jun;17(6):685-93. doi: 10.1016/j.jocn.2009.11.020. Review.

PMID:
20399668
10.

Recombinant activated factor VIIa for the treatment of bleeding in major abdominal surgery including vascular and urological surgery: a review and meta-analysis of published data.

von Heymann C, Jonas S, Spies C, Wernecke KD, Ziemer S, Janssen D, Koscielny J.

Crit Care. 2008;12(1):R14. doi: 10.1186/cc6788. Epub 2008 Feb 15. Review.

11.

Prophylactic activated recombinant factor VII in liver resection and liver transplantation: systematic review and meta-analysis.

Chavez-Tapia NC, Alfaro-Lara R, Tellez-Avila F, Barrientos-Gutiérrez T, González-Chon O, Mendez-Sanchez N, Uribe M.

PLoS One. 2011;6(7):e22581. doi: 10.1371/journal.pone.0022581. Epub 2011 Jul 27. Review.

12.

Recombinant factor VIIa for uncontrollable bleeding in patients with extracorporeal membrane oxygenation: report on 15 cases and literature review.

Repessé X, Au SM, Bréchot N, Trouillet JL, Leprince P, Chastre J, Combes A, Luyt CE.

Crit Care. 2013 Mar 25;17(2):R55. doi: 10.1186/cc12581. Review.

13.

Evidence for the use of recombinant factor VIIa in the prevention and treatment of bleeding in patients without hemophilia.

Birchall J, Stanworth SJ, Duffy MR, Doree CJ, Hyde C.

Transfus Med Rev. 2008 Jul;22(3):177-87. doi: 10.1016/j.tmrv.2008.02.007. Review.

PMID:
18572094
14.

Use of recombinant factor VIIa for the prevention and treatment of bleeding in patients without hemophilia: a systematic review and meta-analysis.

Lin Y, Stanworth S, Birchall J, Doree C, Hyde C.

CMAJ. 2011 Jan 11;183(1):E9-19. doi: 10.1503/cmaj.100408. Epub 2010 Nov 15. Review.

15.

Use of recombinant factor VIIa in inherited and acquired von Willebrand disease.

Sucker C, Scharf RE, Zotz RB.

Clin Appl Thromb Hemost. 2009 Feb;15(1):27-31. doi: 10.1177/1076029607310920. Epub 2008 Feb 8. Review.

PMID:
18263636

Supplemental Content

Support Center